Papakrivopoulou, Eugenia, Vasilopoulou, Elisavet, Lindenmeyer, Maja T, Pacheco, Sabrina, Brzóska, Hortensja ?, Price, Karen L, Kolatsi-Joannou, Maria, White, Kathryn E, Henderson, Deborah J, Dean, Charlotte H, and others. (2018) Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury. Journal of Pathology, 246 (4). pp. 485-496. ISSN 0022-3417. (doi:10.1002/path.5158) (KAR id:69815)
PDF
Author's Accepted Manuscript
Language: English |
|
Download this file (PDF/8MB) |
Preview |
Request a format suitable for use with assistive technology e.g. a screenreader | |
PDF
Pre-print
Language: English |
|
Download this file (PDF/2MB) |
Preview |
Request a format suitable for use with assistive technology e.g. a screenreader | |
Official URL: https://doi.org/10.1002/path.5158 |
Abstract
Planar cell polarity (PCP) pathways control the orientation and alignment of epithelial cells
within tissues. Van Gogh-like 2 (Vangl2) is a key PCP protein that is required for normal
differentiation of kidney glomeruli and tubules. Vangl2 has also been implicated in
modifying the course of acquired glomerular disease and here we further explored how
Vangl2 impacts on glomerular pathobiology in this context. Targeted genetic deletion of
Vangl2 in mouse glomerular epithelial podocytes enhanced the severity of not only
irreversible accelerated nephrotoxic nephritis but also lipopolysaccharide-induced
reversible glomerular damage. In each proteinuric model, genetic deletion of Vangl2 in
podocytes was associated with an increased ratio of active-MMP9 to inactive MMP9, an
enzyme involved in tissue remodelling. Additionally, by interrogating microarray data from
two cohorts of renal patients, we report increased VANGL2 transcript levels in glomeruli of
individuals with focal segmental glomerulosclerosis, suggesting that the molecule may also
be involved in certain human glomerular diseases. These observations support the
conclusion that Vangl2 modulates glomerular injury, at least in part by acting as a brake on
MMP9, a potentially harmful endogenous enzyme.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.1002/path.5158 |
Uncontrolled keywords: | glomerulus, kidney disease, matrix metalloproteinase, planar cell polarity, podocyte |
Subjects: |
Q Science > QR Microbiology R Medicine |
Divisions: | Divisions > Division of Natural Sciences > Medway School of Pharmacy |
Depositing User: | Elisavet Vasilopoulou |
Date Deposited: | 27 Oct 2018 15:36 UTC |
Last Modified: | 05 Nov 2024 12:32 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/69815 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):